Job Description

About Monarch Investment Management:

Monarch Investment Management launched in 2025, and is a New-York based long-biased therapeutics fund with a focus on commercial-stage/near-term commercial stage biopharma companies.

Position Summary:

Qualified candidates will possess a strong ability to analyze both catalyst setups and longer-term/longer-duration investments. While the fund concentrates in long bets that are 12-18+ month duration with a commercial/near-term commercial focus (already launched products or products launching within 18 months), investments are analyzed and made upstream of this that often carry clinical risk. The portfolio also employs a barbell approach between under-valued large and mega-caps as well as high-growth smid-caps/emerging mid-caps. Examples of top concentrated positions over the past several years have been LLY, SGEN, ALNY, VRTX, VRNA, RVMD, ACLX and BLTE.

The senior analyst will also travel to medical meetings and broker conferences, and be able to analyze complex information and data (both clinical and commercial) and translate these insights into actionable investment ideas as well as written deliverables. These ideas will often be invested in, so the qualified candidate should be able to both support research on existing ideas as well as generate new ones upon starting at the firm. 

Qualifications:

• Bachelor’s degree in a STEM major from a top-ranked university, top GPA/test scores (please disclose any relevant SAT, ACT, IQ exam scores etc.)

• 5+ years in the biotechnology/pharmaceutical sector either in clinical, scientific, financial services, or industry capacity

• 2+ years of experience as a buy-side investment analyst covering biotech/pharmaceuticals, ideally at a public-equities focused fund

• Proven ability to interpret clinical and scientific data and translate findings into investment implications and recommendations

• Strong financial modeling, valuation, and analytical abilities. Rigorous attention to detail and ability to communicate articulately and directly both in team meetings and through write-ups/research notes. Understanding of various types of valuation methodology including comparables/multiples analysis, revenue/DCF and SOTP models, market/revenue builds, etc. 

• High integrity, entrepreneurial spirit and strong work ethic, and willingness to adapt and learn in a meritocratic and high-performance startup fund environment

• Strong commitment to team-work, willingness to mentor and manage junior colleagues/analysts at the firm

• Advanced degree (MD/PhD) from a top-ranked university preferred, but not required

The anticipated base salary range for this position is $150,000. Actual compensation will depend on a number of factors, including experience, qualifications, skills, role scope, and performance. This range represents the company’s good-faith estimate at the time of posting and does not include discretionary bonus, incentive compensation, or benefits.  The company will also provide discretionary bonus compensation that may include participation in the upside of the fund as a percentage of the fund economics, subject to eligibility and applicable plan terms.